{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T05:17:48Z","timestamp":1795065468010,"version":"4.10.2"},"reference-count":168,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005199","name":"Chinese Medicine Research Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2022ZB017"],"award-info":[{"award-number":["2022ZB017"]}],"id":[{"id":"10.13039\/501100005199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.isci.2026.117696","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:11:50Z","timestamp":1790068310000},"page":"117696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding the role of cancer-associated fibroblasts in cisplatin resistance of head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"29","author":[{"given":"Dongmei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingnuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117696_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.117696_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ijrobp.2025.05.086","article-title":"Chemoradiation therapy with Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer-Mature Results of the ARTSCAN III Trial","volume":"123","author":"Gebre-Medhin","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.isci.2026.117696_bib6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1470-2045(24)00100-1","article-title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","volume":"25","author":"Machiels","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib7","article-title":"Neoadjuvant immunotherapy with or without chemotherapy in locally advanced oral squamous cell carcinoma: Randomized, two-arm, phase 2 trial","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2026.117696_bib143","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/hed.28245","article-title":"Swallowing and Communication Outcomes Post Chemoradiotherapy for Low-Risk Human Papillomavirus (HPV)-Associated Oropharyngeal Squamous Cell Carcinoma: A Substudy of TROG 12.01","volume":"47","author":"Hughes","year":"2025","journal-title":"Head Neck"},{"key":"10.1016\/j.isci.2026.117696_bib144","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106087","article-title":"Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer","volume":"134","author":"Hitt","year":"2022","journal-title":"Oral Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib146","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.20.02072","article-title":"ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer","volume":"39","author":"Gebre-Medhin","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib147","first-page":"625","article-title":"Effect of Maitake D-fraction in advanced laryngeal and pharyngeal cancers during concurrent chemoradiotherapy: A randomized clinical trial","volume":"69","author":"Hu","year":"2022","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.isci.2026.117696_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105517","article-title":"Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trial","volume":"122","author":"Menon","year":"2021","journal-title":"Oral Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib149","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.radonc.2021.01.032","article-title":"A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma","volume":"157","author":"Yang","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejca.2021.03.051","article-title":"Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial","volume":"151","author":"Keil","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib151","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2021.04.015","article-title":"Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study","volume":"111","author":"Rischin","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.isci.2026.117696_bib152","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1080\/01635581.2024.2352185","article-title":"Prophylactic Versus Reactive Megestrol Acetate Use for Critical Body Weight Loss in Patients with Pharyngeal and Laryngeal Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy","volume":"76","author":"Lin","year":"2024","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib153","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/hed.26635","article-title":"Phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin\/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma","volume":"43","author":"Ang","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.isci.2026.117696_bib154","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.annonc.2025.07.004","article-title":"Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501\/EORTC 22931","volume":"36","author":"Zumsteg","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12916-024-03541-6","article-title":"Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker","volume":"22","author":"Jiang","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.isci.2026.117696_bib156","doi-asserted-by":"crossref","first-page":"18081","DOI":"10.1007\/s00432-023-05497-1","article-title":"A prospective phase II randomized study of docetaxel combined with lobaplatin versus TPF regimen induction chemotherapy followed by concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma","volume":"149","author":"Zhang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib157","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/s41591-024-03110-7","article-title":"Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial","volume":"30","author":"Shi","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2026.117696_bib158","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1200\/JCO.22.00332","article-title":"Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent\/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651","volume":"41","author":"Haddad","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib135","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1186\/s12885-023-11316-0","article-title":"Pembrolizumab plus epacadostat in patients with recurrent\/metastatic head and neck squamous cell carcinoma (KEYNOTE-669\/ECHO-304): a phase 3, randomized, open-label study","volume":"23","author":"Cho","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib159","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s10147-022-02233-6","article-title":"First-line pembrolizumab \u00b1 chemotherapy for recurrent\/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048","volume":"27","author":"Takahashi","year":"2022","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12032-023-02234-z","article-title":"Repurposing pantoprazole in combination with systemic therapy in advanced head and neck squamous cell carcinoma: a phase I\/II randomized study","volume":"41","author":"Noronha","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib161","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000521415","article-title":"Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial","volume":"45","author":"Goerling","year":"2022","journal-title":"Oncol. Res. Treat."},{"key":"10.1016\/j.isci.2026.117696_bib162","first-page":"350","article-title":"Clinical efficacy of induction chemoimmunotherapy for locally advanced hypopharyngeal carcinoma: a prospective phase \u2161 study","volume":"59","author":"Gong","year":"2024","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10.1016\/j.isci.2026.117696_bib163","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1664892","article-title":"Efficacy and safety of the neoadjuvant chemoimmunotherapy with pembrolizumab plus docetaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117696_bib164","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1038\/s41467-024-46444-z","article-title":"Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117696_bib165","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1158\/1078-0432.CCR-25-1445","article-title":"Cadonilimab (a PD-1\/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial","volume":"31","author":"Cao","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117696_bib166","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1038\/s41467-025-59865-1","article-title":"Neoadjuvant with low-dose radiotherapy, tislelizumab, albumin-bound paclitaxel, and cisplatin for resectable locally advanced head and neck squamous cell carcinoma: phase II single-arm trial","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117696_bib167","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1158\/2767-9764.CRC-23-0051","article-title":"Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer","volume":"3","author":"Moutafi","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.isci.2026.117696_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113560","article-title":"Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer","volume":"200","author":"Noronha","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib169","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4143\/crt.2024.1025","article-title":"Phase II Trial of Neoadjuvant Docetaxel\/Cisplatin\/5-Fluorouracil Combined with Pegteograstim for Unresectable, Locally Advanced Sinonasal Squamous Cell Carcinoma: KCSG HN18-07","volume":"57","author":"Keam","year":"2025","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.isci.2026.117696_bib170","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13046-022-02510-2","article-title":"Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib clinical trial","volume":"41","author":"Huang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117696_bib171","first-page":"335","article-title":"Phase \u2161 clinical trial of PD-1 inhibitor combined with chemotherapy for locally advanced resectable oral squamous cell carcinoma","volume":"59","author":"Wang","year":"2024","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10.1016\/j.isci.2026.117696_bib10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","article-title":"Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma","volume":"21","author":"Provenzano","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117696_bib11","doi-asserted-by":"crossref","first-page":"76116","DOI":"10.18632\/oncotarget.18814","article-title":"Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6\/STAT3 signaling pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.117696_bib12","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117696_bib13","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3390\/ijms22041912","article-title":"Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts","volume":"22","author":"Peltanova","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117696_bib14","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1200\/JCO.1994.12.6.1193","article-title":"Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts","volume":"12","author":"Welt","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ijc.2910590107","article-title":"Phenotypic heterogeneity in breast fibroblasts: functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma","volume":"59","author":"Schor","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib16","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1090922","article-title":"TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia","volume":"303","author":"Bhowmick","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.117696_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ccr.2005.05.019","article-title":"Coevolution of cancer and stromal cellular responses","volume":"7","author":"Littlepage","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117696_bib19","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI26532","article-title":"Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake","volume":"116","author":"Loeffler","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117696_bib20","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.4161\/cbt.5.12.3354","article-title":"Identification of fibroblast heterogeneity in the tumor microenvironment","volume":"5","author":"Sugimoto","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.isci.2026.117696_bib21","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2353\/ajpath.2007.060661","article-title":"Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment","volume":"171","author":"Mueller","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2026.117696_bib22","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","article-title":"Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts","volume":"67","author":"Zeisberg","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117696_bib23","doi-asserted-by":"crossref","first-page":"8492","DOI":"10.1158\/0008-5472.CAN-04-1708","article-title":"Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts","volume":"64","author":"Direkze","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117696_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13402-011-0012-1","article-title":"Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors","volume":"34","author":"Jotzu","year":"2011","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.matbio.2008.02.008","article-title":"Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells","volume":"27","author":"Serebriiskii","year":"2008","journal-title":"Matrix Biol."},{"key":"10.1016\/j.isci.2026.117696_bib26","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4161\/cbt.7.8.6264","article-title":"Differential impact of fibroblasts on the efficient cell death of lung cancer cells induced by paclitaxel and cisplatin","volume":"7","author":"Bartling","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.isci.2026.117696_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.1","article-title":"Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells","volume":"3","author":"Kharaziha","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.117696_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045669","article-title":"Low ERK phosphorylation in cancer-associated fibroblasts is associated with tamoxifen resistance in pre-menopausal breast cancer","volume":"7","author":"Busch","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2026.117696_bib29","first-page":"957","article-title":"Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma","volume":"21","author":"Chuaysri","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.isci.2026.117696_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-8-1","article-title":"IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients","volume":"8","author":"Rajski","year":"2010","journal-title":"BMC Med."},{"key":"10.1016\/j.isci.2026.117696_bib31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3748\/wjg.v18.i8.840","article-title":"Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance","volume":"18","author":"Shi","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.isci.2026.117696_bib32","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/j.1365-2559.2011.04060.x","article-title":"Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma","volume":"59","author":"Pula","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.isci.2026.117696_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/1476-4598-9-168","article-title":"Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts","volume":"9","author":"Haubeiss","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/path.4281","article-title":"Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis","volume":"231","author":"Sandoval","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.isci.2026.117696_bib35","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.celrep.2015.11.052","article-title":"Cdc42EP3\/BORG2 and Septin Network Enables Mechano-transduction and the Emergence of Cancer-Associated Fibroblasts","volume":"13","author":"Calvo","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117696_bib36","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.oraloncology.2015.08.017","article-title":"Tumor necrosis factor \u03b1 induces myofibroblast differentiation in human tongue cancer and promotes invasiveness and angiogenesis via secretion of stromal cell-derived factor-1","volume":"51","author":"Zhou","year":"2015","journal-title":"Oral Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/cdd.2015.78","article-title":"Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling","volume":"23","author":"Tang","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.isci.2026.117696_bib38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00262-015-1742-0","article-title":"Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma","volume":"64","author":"Takahashi","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.isci.2026.117696_bib39","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/onc.2017.65","article-title":"Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1","volume":"36","author":"Cohen","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.117696_bib40","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","article-title":"Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells","volume":"9","author":"Lakins","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117696_bib41","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1158\/1078-0432.CCR-14-0846","article-title":"Podoplanin-positive cancer-associated fibroblasts in the tumor microenvironment induce primary resistance to EGFR-TKIs in lung adenocarcinoma with EGFR mutation","volume":"21","author":"Yoshida","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117696_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.15252\/emmm.201404346","article-title":"Pharmacological targeting of the protein synthesis mTOR\/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance","volume":"7","author":"Duluc","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2026.117696_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.225","article-title":"Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death","volume":"8","author":"Cheteh","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.117696_bib44","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.celrep.2015.02.006","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by IDH3\u03b1 downregulation","volume":"10","author":"Zhang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117696_bib45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12885-015-1117-0","article-title":"A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer","volume":"15","author":"Hosein","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib46","first-page":"263","article-title":"The relationship between the expressions of tumor associated fibroblasts Cav-1 and MCT4 and the prognosis of papillary carcinoma of breast","volume":"30","author":"Zhai","year":"2017","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.isci.2026.117696_bib47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7150\/ijbs.10666","article-title":"Caveolin-1 is a modulator of fibroblast activation and a potential biomarker for gastric cancer","volume":"11","author":"Shen","year":"2015","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.isci.2026.117696_bib48","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djs336","article-title":"Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug","volume":"104","author":"Brennen","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.isci.2026.117696_bib50","article-title":"Cancer-associated fibroblasts in the tumor microenvironment of tongue carcinoma is a heterogeneous cell population","volume":"121","author":"Vered","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.117696_bib51","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117696_bib52","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.117696_bib53","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","article-title":"Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment","volume":"13","author":"Luo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117696_bib54","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117696_bib55","doi-asserted-by":"crossref","first-page":"460","DOI":"10.7150\/thno.87329","article-title":"Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma via miR-876-3p","volume":"14","author":"Kang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.117696_bib56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41698-023-00460-2","article-title":"Chemoresistant fibroblasts dictate neoadjuvant chemotherapeutic response of head and neck cancer via TGF\u03b1-EGFR paracrine signaling","volume":"7","author":"Su","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122239","article-title":"Synergetic impact of combined navoximod with cisplatin mitigates chemo-immune resistance via blockading IDO1 CAFs-secreted Kyn\/AhR\/IL-6 and pol \u03b6-prevented CIN in human oral squamous cell carcinoma","volume":"335","author":"Chen","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.isci.2026.117696_bib58","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.3390\/ijms22158245","article-title":"Differential Angiogenic Potential of 3-Dimension Spheroid of HNSCC Cells in Mouse Xenograft","volume":"22","author":"Choi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.117696_bib60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s40164-025-00713-9","article-title":"Brain metastasis-associated cancer fibroblasts drive tumor progression and therapeutic resistance through IL26 and CX3CL1 signaling in non-small-cell lung cancer","volume":"14","author":"Salam","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib61","article-title":"Rab27a+CAF exosomal miR-9-5p promotes osteosarcoma progression via CREBRF\/MAPK signaling pathway","volume":"134","author":"Salam","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.isci.2026.117696_bib62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41419-024-06671-0","article-title":"Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2026.117696_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70025","article-title":"IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer","volume":"28","author":"Wu","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.isci.2026.117696_bib64","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001639","article-title":"An \u03b1-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer","author":"Ren","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2026.117696_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102080","article-title":"PPIC-labeled CAFs: Key players in neoadjuvant chemotherapy resistance for gastric cancer","volume":"48","author":"Yin","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib66","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/CAD.0000000000001445","article-title":"Cancer-associated fibroblasts-derived exosomes from chemoresistant patients regulate cisplatin resistance and angiogenesis by delivering VEGFA in colorectal cancer","volume":"34","author":"Shi","year":"2023","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.isci.2026.117696_bib172","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1038\/s41598-025-87808-9","article-title":"E2F1 activates breast stromal fibroblasts and promotes their paracrine pro-carcinogenic effects","volume":"15","author":"Al-Kharashi","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117696_bib173","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/cjp2.333","article-title":"Cancer-associated fibroblast expression of glutamine fructose-6-phosphate aminotransferase 2 (GFPT2) is a prognostic marker in gastric cancer","volume":"9","author":"Yang","year":"2023","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.isci.2026.117696_bib174","article-title":"Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips","volume":"26","author":"Wu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.117696_bib49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12935-024-03388-0","article-title":"Tumor-matched and unmatched cancer associated fibroblasts exhibit differential effect on proliferation and FMOD and MMP9 gene expression in head and neck squamous cell carcinoma cells when cocultured in spheroids","volume":"24","author":"Rademaekers","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.isci.2026.117696_bib68","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s12935-020-01718-6","article-title":"CAFs affect the proliferation and treatment response of head and neck cancer spheroids during co-culturing in a unique in vitro model","volume":"20","author":"Magan","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.isci.2026.117696_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1302016","article-title":"Mapping knowledge structure and themes trends of cancer-associated fibroblasts: a text-mining study","volume":"10","author":"Cheng","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.isci.2026.117696_bib70","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3390\/cancers11111766","article-title":"Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1","volume":"11","author":"Lai","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2026.117696_bib71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/cancers12010056","article-title":"Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21\/STAT3\/\u03b2-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts","volume":"12","author":"Chen","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2026.117696_bib72","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13402-021-00592-2","article-title":"Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt\/\u03b2-catenin pathway","volume":"44","author":"Xie","year":"2021","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13059-018-1604-0","article-title":"Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5","volume":"20","author":"Qin","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2026.117696_bib67","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopha.2017.11.024","article-title":"Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation","volume":"97","author":"Liao","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.isci.2026.117696_bib74","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jcms.2017.12.016","article-title":"Investigation of cancer-associated fibroblasts and p62 expression in oral cancer before and after chemotherapy","volume":"46","author":"Liang","year":"2018","journal-title":"J. Cranio-Maxillofacial Surg."},{"key":"10.1016\/j.isci.2026.117696_bib75","doi-asserted-by":"crossref","first-page":"6679","DOI":"10.1158\/0008-5472.CAN-17-1077","article-title":"Secretory Autophagy in Cancer-Associated Fibroblasts Promotes Head and Neck Cancer Progression and Offers a Novel Therapeutic Target","volume":"77","author":"New","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117696_bib76","article-title":"Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2026.117696_bib77","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1158\/0008-5472.CAN-17-1076","article-title":"Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression","volume":"78","author":"Kumar","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117696_bib78","article-title":"Cancer-associated fibroblasts-derived CXCL1 activates DEC2-mediated dormancy in oral squamous cell carcinoma","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.isci.2026.117696_bib79","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cmet.2018.09.012","article-title":"Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy","volume":"29","author":"Bertero","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2026.117696_bib80","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4350783","article-title":"Knockdown of Matrix Metallopeptidase 9 Inhibits Metastasis of Oral Squamous Cell Carcinoma Cells in a Zebrafish Xenograft Model","volume":"2020","author":"Wen","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.isci.2026.117696_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108201","article-title":"Fibromodulin overexpression drives oral squamous cell carcinoma via activating downstream EGFR signaling","volume":"26","author":"Xia","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.117696_bib82","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41556-022-00843-w","article-title":"Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance","volume":"24","author":"Romani","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2026.117696_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117335","article-title":"Exploiting mechanoregulation via FAK\/YAP to overcome platinum resistance in ovarian cancer","volume":"179","author":"Dang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.isci.2026.117696_bib84","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.canlet.2021.06.009","article-title":"Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6\/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma","volume":"518","author":"Zhao","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.117696_bib85","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cell.2016.04.009","article-title":"Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer","volume":"165","author":"Wang","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117696_bib86","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12032-023-01953-7","article-title":"CAFs secrete CXCL12 to accelerate the progression and cisplatin resistance of colorectal cancer through promoting M2 polarization of macrophages","volume":"40","author":"Jiang","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101273","article-title":"The multifaceted contributions of cancer-associated fibroblasts to drug resistance in primary and metastatic tumors","volume":"82","author":"Zhang","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.isci.2026.117696_bib88","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/odi.15130","article-title":"CAF-secreted COL5A2 activates the PI3K\/AKT pathway to mediate erlotinib resistance in head and neck squamous cell carcinoma","volume":"31","author":"Guo","year":"2025","journal-title":"Oral Dis."},{"key":"10.1016\/j.isci.2026.117696_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1545762","article-title":"Multi-omics analysis of the dynamic role of STAR+ cells in regulating platinum-based chemotherapy responses and tumor microenvironment in serous ovarian carcinoma","volume":"16","author":"Lan","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2026.117696_bib90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib92","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/labinvest.2015.163","article-title":"Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma","volume":"96","author":"Lee","year":"2016","journal-title":"Lab. Invest."},{"key":"10.1016\/j.isci.2026.117696_bib91","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.3390\/cancers15225320","article-title":"Optimization of a Three-Dimensional Culturing Method for Assessing the Impact of Cisplatin on Notch Signaling in Head and Neck Squamous Cell Carcinoma (HNSCC)","volume":"15","author":"Anameri\u00e7","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.isci.2026.117696_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.113911","article-title":"Stroma modulation of radiation response in head and neck squamous cell carcinoma: Insights from zebrafish larvae xenografts","volume":"435","author":"Wahbi","year":"2024","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.isci.2026.117696_bib94","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4825108","article-title":"Isolation of Fibroblast-Activation Protein-Specific Cancer-Associated Fibroblasts","volume":"2017","author":"Huang","year":"2017","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.isci.2026.117696_bib95","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12032-013-0674-9","article-title":"Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion","volume":"30","author":"Yu","year":"2013","journal-title":"Med. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.694","article-title":"Single-cell RNA sequencing technologies and applications: A brief overview","volume":"12","author":"Jovic","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.isci.2026.117696_bib97","article-title":"Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling","volume":"1878","author":"Raudenska","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.isci.2026.117696_bib98","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s12943-025-02461-0","article-title":"Emerging role of cancer-associated fibroblasts in the premetastatic niche","volume":"24","author":"Yang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib99","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009494","article-title":"Cancer-associated fibroblasts shape early myeloid cell response to chemotherapy-induced immunogenic signals in next generation tumor organoid cultures","volume":"12","author":"Kabiljo","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.117696_bib100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1039\/C8LC01240G","article-title":"3D arrays of microcages by two-photon lithography for spatial organization of living cells","volume":"19","author":"Larramendy","year":"2019","journal-title":"Lab Chip"},{"key":"10.1016\/j.isci.2026.117696_bib101","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12964-025-02073-7","article-title":"A novel therapeutic approach targeting PD-L1 in HNSCC and bone marrow-derived mesenchymal stem cells hampers pro-metastatic features in vitro: perspectives for blocking tumor-stroma communication and signaling","volume":"23","author":"Ferrara","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.isci.2026.117696_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218242","article-title":"A Pt (IV)\/losartan\/immunotherapy Co-delivery thermosensitive gel synergizes STING activation and cancer-associated fibroblast inhibition for ovarian cancer chemoimmunotherapy","volume":"639","author":"Liu","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.117696_bib103","article-title":"Senescence-associated secretory phenotype regulation by dual drug delivery biomimetic nanoplatform for enhanced tumor chemotherapy","volume":"32","author":"Wang","year":"2024","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib104","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.actbio.2026.02.018","article-title":"Visible tumor-targeting biohybrid vehicles reprogram cancer-associated fibroblasts to potentiate photothermal immunotherapy","volume":"213","author":"Jin","year":"2026","journal-title":"Acta Biomater."},{"key":"10.1016\/j.isci.2026.117696_bib105","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1021\/acsnano.4c01499","article-title":"Breaking Physical Barrier of Fibrotic Breast Cancer for Photodynamic Immunotherapy by Remodeling Tumor Extracellular Matrix and Reprogramming Cancer-Associated Fibroblasts","volume":"18","author":"Qiu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.isci.2026.117696_bib106","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nano.2015.10.001","article-title":"A tenascin C targeted nanoliposome with navitoclax for specifically eradicating of cancer-associated fibroblasts","volume":"12","author":"Chen","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.isci.2026.117696_bib107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2016.09.014","article-title":"Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system","volume":"241","author":"Chen","year":"2016","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.isci.2026.117696_bib108","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.2147\/IJN.S171224","article-title":"Prior anti-CAFs break down the CAFs barrier and improve accumulation of docetaxel micelles in tumor","volume":"13","author":"Pang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.isci.2026.117696_bib109","doi-asserted-by":"crossref","first-page":"10102","DOI":"10.1021\/acsami.1c23166","article-title":"Sequential Delivery of Quercetin and Paclitaxel for the Fibrotic Tumor Microenvironment Remodeling and Chemotherapy Potentiation via a Dual-Targeting Hybrid Micelle-in-Liposome System","volume":"14","author":"Duan","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.isci.2026.117696_bib110","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2147\/IJN.S427783","article-title":"Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis","volume":"19","author":"Li","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.isci.2026.117696_bib111","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00259-024-06952-y","article-title":"Enhancing the tissue penetration to improve sonodynamic immunotherapy for pancreatic ductal adenocarcinoma using membrane-camouflaged nanoplatform","volume":"52","author":"Du","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.isci.2026.117696_bib112","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.actbio.2022.03.050","article-title":"Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming","volume":"145","author":"Zhao","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.isci.2026.117696_bib113","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1002\/anie.202014397","article-title":"Transformable Honeycomb-Like Nanoassemblies of Carbon Dots for Regulated Multisite Delivery and Enhanced Antitumor Chemoimmunotherapy","volume":"60","author":"Hou","year":"2021","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.isci.2026.117696_bib114","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2017.06.022","article-title":"Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy","volume":"261","author":"Mpekris","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.isci.2026.117696_bib115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s13402-023-00888-5","article-title":"FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC","volume":"47","author":"Liu","year":"2024","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib116","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ccr.2014.04.005","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"25","author":"\u00d6zdemir","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117696_bib117","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41420-023-01428-8","article-title":"Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma: opportunities and challenges","volume":"9","author":"Hu","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.isci.2026.117696_bib118","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200712","article-title":"Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC","volume":"218","author":"Sharma","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2026.117696_bib119","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mc.23668","article-title":"Cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1\u03b1\/miR-21 axis under hypoxic conditions in pancreatic cancer","volume":"63","author":"Deng","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.isci.2026.117696_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101275","article-title":"Hypoxia-induced upregulation of HIF1A-AS3 promotes MSC transition to cancer-associated fibroblasts and confers drug resistance in gastric cancer","volume":"82","author":"Xu","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.isci.2026.117696_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2022.100854","article-title":"FAP\u03b1 and \u03b1SMA mark different subsets of fibroblasts in normal kidney and conventional renal cell carcinoma","volume":"35","author":"Peterfi","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.isci.2026.117696_bib122","first-page":"2358","article-title":"Phase I trial of sonidegib (SMOi) in combination with docetaxel in patients with advanced solid tumors: EDALINE study","volume":"9","author":"Cueva","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117696_bib123","series-title":"Identification of Tumor Cell- and Stroma Derived Biomarkers of Treatment Response in Head and Neck Cancer. PhD Thesis","author":"K\u00e5rehed","year":"2016"},{"key":"10.1016\/j.isci.2026.117696_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.120029","article-title":"Cancer-associated fibroblasts secreting IL-6 inhibit the cisplatin and docetaxel killing effect in lung squamous cell carcinoma","volume":"1872","author":"Zhu","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.isci.2026.117696_bib125","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s12149-025-02056-1","article-title":"Feasibility and mechanism of 68Ga-FAPI PET\/CT in monitoring chemoresistance of non-small cell lung cancer","volume":"39","author":"Hua","year":"2025","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.isci.2026.117696_bib126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.semcancer.2020.12.024","article-title":"Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer","volume":"77","author":"Ghoneum","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.isci.2026.117696_bib127","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1158\/1541-7786.MCR-09-0460","article-title":"Cancer-associated fibroblasts derived from EGFR-TKI-resistant tumors reverse EGFR pathway inhibition by EGFR-TKIs","volume":"8","author":"Mink","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.isci.2026.117696_bib128","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1158\/1541-7786.MCR-12-0030","article-title":"Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells","volume":"10","author":"Johansson","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.isci.2026.117696_bib129","doi-asserted-by":"crossref","first-page":"34288","DOI":"10.18632\/oncotarget.5924","article-title":"Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer","volume":"6","author":"Schmitz","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.117696_bib130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ebiom.2019.01.062","article-title":"PDGFR\u03b1 inhibition in soft-tissue sarcomas: Have we gotten it all wrong?","volume":"40","author":"Napolitano","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.117696_bib131","first-page":"61","article-title":"Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer","volume":"7","author":"D'Arcangelo","year":"2013","journal-title":"Biologics."},{"key":"10.1016\/j.isci.2026.117696_bib132","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/1535-7163.MCT-12-0431","article-title":"Stromal platelet-derived growth factor receptor \u03b1 (PDGFR\u03b1) provides a therapeutic target independent of tumor cell PDGFR\u03b1 expression in lung cancer xenografts","volume":"11","author":"Gerber","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.isci.2026.117696_bib133","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neo.2017.04.004","article-title":"Stromal PDGFR-\u03b1 Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth","volume":"19","author":"Hammer","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.isci.2026.117696_bib134","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13046-025-03487-4","article-title":"Cancer-associated fibroblast derived CXCL14 drives cisplatin chemoresistance by enhancing nucleotide excision repair in bladder cancer","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117696_bib136","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1680896","article-title":"Adverse pro-tumorigenic effects of IDO1 catalytic inhibitors mediated by the non-enzymatic function of IDO1 in tumor cells","volume":"16","author":"Rossini","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2026.117696_bib137","series-title":"Design, Synthesis and Evaluation of Mechanism-Based Inhibitors of Ido1 and PROTAC-Degraders of JAK2","author":"Cundy","year":"2020"},{"key":"10.1016\/j.isci.2026.117696_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31191","article-title":"Development of a high dimensional imaging mass cytometry panel to investigate spatial organization of tissue microenvironment in formalin-fixed archival clinical tissues","volume":"10","author":"Tornaas","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.isci.2026.117696_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101717","article-title":"Heterogeneity of cancer-associated fibroblasts in head and neck squamous cell carcinoma","volume":"35","author":"Mou","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.isci.2026.117696_bib140","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1084\/jem.20190158","article-title":"Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis","volume":"216","author":"Dai","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2026.117696_bib141","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-Induced JAK\/STAT Signaling Is Antagonized by TGF\u03b2 to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.isci.2026.117696_bib142","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3892\/ijo.2016.3442","article-title":"Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K\/Akt signaling pathways","volume":"48","author":"Zhou","year":"2016","journal-title":"Int. J. Oncol."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226030774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226030774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:52:14Z","timestamp":1795063934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226030774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":168,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2589004226030774"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117696","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding the role of cancer-associated fibroblasts in cisplatin resistance of head and neck squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117696"}}